COVID-19 presentations and outcome in patients with epilepsy
Category
Research
-
-
Breaking newsCOVID-19Research
Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain
March 3, 2021Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain -
Breaking newsResearchCOVID-19
Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19
March 3, 2021Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19 -
Breaking newsResearchCOVID-19
COVID 19-induced smell and taste impairments: Putative impact on physiology
March 3, 2021COVID 19-induced smell and taste impairments: Putative impact on physiology -
Breaking newsResearchCOVID-19
COVID-19 Pathophysiology predicts that ischaemic stroke occurrence is an expectation, not an exception—A systematic review
March 3, 2021COVID-19 Pathophysiology predicts that ischaemic stroke occurrence is an expectation, not an exception—A systematic review -
Breaking newsCOVID-19Research
Infection mechanism of SARS-COV-2 and its implication on the nervous system
March 3, 2021Infection mechanism of SARS-COV-2 and its implication on the nervous system -
Breaking newsResearchCOVID-19
Cognitive decline among individuals with history of mild symptomatic SARS‐CoV‐2 infection. A longitudinal prospective study nested to a population cohort.
March 3, 2021Cognitive decline among individuals with history of mild symptomatic SARS‐CoV‐2 infection. A longitudinal prospective study nested to a population cohort. -
Breaking newsResearchCOVID-19
Acute‐onset delirium in intensive care COVID patients: association of imperfect brain repair with foodborne micro‐pollutants
March 3, 2021Acute‐onset delirium in intensive care COVID patients: association of imperfect brain repair with foodborne micro‐pollutants -
Breaking newsResearchCOVID-19
Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis
March 3, 2021Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis -
Breaking newsResearchCOVID-19
Incidence and impact of COVID-19 in MS. A survey from a Barcelona MS unit
March 3, 2021Incidence and impact of COVID-19 in MS. A survey from a Barcelona MS unit -
Breaking newsResearchCOVID-19
Presence of SARS-CoV-2 transcripts in the choroid plexus of MS and non-MS patients with COVID-19
March 3, 2021Presence of SARS-CoV-2 transcripts in the choroid plexus of MS and non-MS patients with COVID-19 -
COVID-19 and the human innate immune system
-
Breaking newsCOVID-19Research
Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids
March 3, 2021Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids -
Breaking newsResearchCOVID-19
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
March 3, 2021Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection -
Breaking newsResearchCOVID-19
Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell derived lung and cerebral organoids
March 3, 2021Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell derived lung and cerebral organoids